No images? Click here Welcome to The Corner. In this issue, we explore the ramifications of Amazon’s takeover of One Medical, which broaches both antitrust and privacy issues. Amazon Invites Antitrust Scrutiny with Takeover of One Medical Luke Goldstein Last week, Amazon announced a $3.9 billion plan to buy One Medical, a network of primary care clinics that provide in-person and virtual care to almost 800,000 patients around the country. The online retail and distribution giant took the action even as it faces an investigation by the FTC into its purchase of iconic studio MGM, a lawsuit filed by Washington, D.C. Attorney General Karl Racine, as well as heightened scrutiny from Congress in the form of an antitrust bill designed to stop the corporation from steering buyers to its own products. Amazon may believe it can sneak the deal past antitrust agencies since its footprint in healthcare remains small compared to its retail and entertainment arms. But there's a number of reasons to believe law enforcers will move to block the deal. Two concerns especially stand out. First, the corporation already controls a business called Amazon Care, which started as an internal health program but has since expanded to offer service to outside businesses. Amazon has also launched a diagnostics service that sells its own medical supplies in the company’s vast online marketplace. And in 2018, Amazon paid $752 million for PillPack, an online pharmacy provider. The potential problem here is simply that Amazon would leverage One Medical to promote other medical devices, pharmacy services, and health care services that the corporation already controls. Or, similarly, that Amazon might wield its existing power over the businesses that rely on the platform to reach customers to induce them to use One Medical to serve their employees, as Senator Amy Klobuchar warned about in this letter to the FTC. “Amazon has a history of engaging in business practices that raise serious anticompetitive concerns, including forcing small businesses on its site to buy its logistics services as a condition of preferred platform placement," Klobuchar's letter reads. Indeed, Amazon has long used similar tactics to strong-arm merchants to sign agreements giving the corporation access to their internal data and sales numbers so that it can compete against them. The second major concern is that Amazon would use One Medical and related services as a way to gain access to patients' health data. One Medical – both through its app and through in-clinic services - already collects vast amounts of health information on its patients. Amazon could use patient’s personal information to target advertising of their own medical and pharmacy services while undercutting other distributors through predatory pricing. Similarly, but even more disturbingly, Amazon might use such information to buttress the personal profiles the corporation uses to manipulate the purchasing decisions of the people who buy and sell on its platforms. "Amazon wants access to as much personal information as possible to push even more invasive advertising onto its users," said Daniel Hanley, senior legal analyst at the Open Markets Institute. It's unclear to what extent HIPAA — a federal law that generally prohibits healthcare businesses from sharing patient information with outside entities — will be able to restrict Amazon's use of One Medical data. Google's recent acquisition of health fitness monitor Fitbit, for example, has revealed the limitations of HIPAA protections for personal data when it comes to new health technology companies that have been able to play by a different set of rules. As a recent whistleblower report showed, Google has already started to pair non-anonymized Fitbit data with patient information from the nonprofit health system Ascension, with which Google has forged a partnership. Typically, a primary health provider wouldn't be allowed to share that kind of information. But Google has been able to circumvent HIPAA by exploiting a loophole that allows health care companies to share patient data with third parties, as long as the data is used to help “carry out its health care functions," according to Mona Sobhani, director of research at the University of Southern California Center for Body Computing. Read the Open Markets statement calling on enforcers to block Amazon’s purchase of One Medical here. 🔊 ANTI-MONOPOLY RISING:
📝 WHAT WE'VE BEEN UP TO:
We appreciate your readership. Please consider making a contribution to support the continued publication of this newsletter. 📈 VITAL STAT:10%+Market share controlled by JetBlue and Spirit after their merger, behind American Airlines (18%), Delta Air Lines and Southwest Airlines (17%), and United Airlines (14%). 📚 WHAT WE'RE READING:
NIKKI USHER'S NEW BOOK
News for the Rich, White, and Blue: How Place and Power Distort American Journalism Nikki Usher, a senior fellow at Open Markets Institute’s Center for Journalism & Liberty, has released her third book, News for the Rich, White, and Blue: How Place and Power Distort American Journalism. In her latest work, Usher offers a frank examination of the inequalities driving not just America’s journalism crisis but also certain portions of the movement to save it. “We need to radically rethink the core functions of journalism, leverage expertise, and consider how to take the best of what the newspaper ethos of journalism can offer to places that have lost geographically specific news, “ says Usher, an associate professor at the University of Illinois-Champaign. “The news that powers democracy can be more inclusive.” Usher is also the author of Making News at The New York Times (2014) and Interactive Journalism: Hackers, Data, and Code (2016). News for the Rich, White, and Blue, published by Columbia University Press, is available as a hardback, paperback and e-book. You can order your copy here. 🔎 TIPS? COMMENTS? SUGGESTIONS? We would love to hear from you—just reply to this e-mail and drop us a line. Give us your feedback, alert us to competition policy news, or let us know your favorite story from this issue. |